104 related articles for article (PubMed ID: 26245074)
1. [Curative treatment of Alzheimer's disease is still missing--is amyloid plaque hypothesis the wrong starting point?].
Tanila H
Duodecim; 2015; 131(3):243-8. PubMed ID: 26245074
[TBL] [Abstract][Full Text] [Related]
2. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.
Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR
Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease amyloid hypothesis at crossroads: where do we go from here?
Saxena U
Expert Opin Ther Targets; 2010 Dec; 14(12):1273-7. PubMed ID: 21058918
[TBL] [Abstract][Full Text] [Related]
4. The amyloid cascade hypothesis has misled the pharmaceutical industry.
Biochem Soc Trans; 2011 Aug; 39(4):920-3. PubMed ID: 21787324
[TBL] [Abstract][Full Text] [Related]
5. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
[TBL] [Abstract][Full Text] [Related]
6. Amyloid plaques are still main target for Alzheimer's drugs.
Hawkes N
BMJ; 2016 Jan; 352():i214. PubMed ID: 26762356
[No Abstract] [Full Text] [Related]
7. Alzheimer's disease: β-amyloid plaque formation in human brain.
Seeman P; Seeman N
Synapse; 2011 Dec; 65(12):1289-97. PubMed ID: 21633975
[TBL] [Abstract][Full Text] [Related]
8. The link between altered cholesterol metabolism and Alzheimer's disease.
Gamba P; Testa G; Sottero B; Gargiulo S; Poli G; Leonarduzzi G
Ann N Y Acad Sci; 2012 Jul; 1259():54-64. PubMed ID: 22758637
[TBL] [Abstract][Full Text] [Related]
9. Plaque busters: strategies to inhibit amyloid formation in Alzheimer's disease.
Soto C
Mol Med Today; 1999 Aug; 5(8):343-50. PubMed ID: 10431167
[TBL] [Abstract][Full Text] [Related]
10. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
[TBL] [Abstract][Full Text] [Related]
11. Why Alzheimer trials fail: removing soluble oligomeric beta amyloid is essential, inconsistent, and difficult.
Rosenblum WI
Neurobiol Aging; 2014 May; 35(5):969-74. PubMed ID: 24210593
[TBL] [Abstract][Full Text] [Related]
12. The incretin analogue D-Ala2GIP reduces plaque load, astrogliosis and oxidative stress in an APP/PS1 mouse model of Alzheimer's disease.
Duffy AM; Hölscher C
Neuroscience; 2013 Jan; 228():294-300. PubMed ID: 23103794
[TBL] [Abstract][Full Text] [Related]
13. Solanezumab and the amyloid hypothesis for Alzheimer's disease.
Le Couteur DG; Hunter S; Brayne C
BMJ; 2016 Dec; 355():i6771. PubMed ID: 28034844
[No Abstract] [Full Text] [Related]
14. [Gamma-secretase inhibitors in Alzheimer's disease therapy].
Katarína S; Jan K; Kamil K; Kamil M
Ceska Slov Farm; 2012 Jun; 61(3):93-100. PubMed ID: 22913824
[TBL] [Abstract][Full Text] [Related]
15. On the origin of Alzheimer's disease. Trials and tribulations of the amyloid hypothesis.
Castello MA; Soriano S
Ageing Res Rev; 2014 Jan; 13():10-2. PubMed ID: 24252390
[TBL] [Abstract][Full Text] [Related]
16. Neuronal driven pre-plaque inflammation in a transgenic rat model of Alzheimer's disease.
Hanzel CE; Pichet-Binette A; Pimentel LS; Iulita MF; Allard S; Ducatenzeiler A; Do Carmo S; Cuello AC
Neurobiol Aging; 2014 Oct; 35(10):2249-62. PubMed ID: 24831823
[TBL] [Abstract][Full Text] [Related]
17. Strategies, development, and pitfalls of therapeutic options for Alzheimer's disease.
Haas C
J Alzheimers Dis; 2012; 28(2):241-81. PubMed ID: 21987594
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of amyloid formation: a strategy to delay the onset of Alzheimer's disease.
Lansbury PT
Curr Opin Chem Biol; 1997 Aug; 1(2):260-7. PubMed ID: 9667848
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy for Alzheimer's disease.
Solomon B; Frenkel D
Neuropharmacology; 2010; 59(4-5):303-9. PubMed ID: 20388523
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease, metal ions and metal homeostatic therapy.
Zatta P; Drago D; Bolognin S; Sensi SL
Trends Pharmacol Sci; 2009 Jul; 30(7):346-55. PubMed ID: 19540003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
